Browse by author
Lookup NU author(s): Denise Johnson
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
INTRODUCTION: Olanzapine oro-dispersible (Velotab™) was introduced to the United Kingdom in May 2000. It rapidly dissolves in the mouth, and therefore patients may find it preferable to swallowing tablets. Another advantage is that the opportunity to hide the medication is much reduced. The study examined the usage of Velotab™ in a forensic psychiatry setting. METHOD: Drug expenditure for different classes of antipsychotic was examined for 6 months before and 7 months after the introduction of olanzapine Velotab™. RESULTS: The results showed a change in prescribing practice, with a significant inverse correlation between the use of Velotab™ and depot medication. CONCLUSION: This suggests that forensic psychiatrists, who may have particular concerns about compliance, had confidence in oro-dispersible administration as an alternative to depot medication. It is suggested that making other neuroleptics available in an oro-dispersible form would allow for a wider choice of atypicals in populations in whom there are significant compliance problems.
Author(s): Johnson D, Rai S, Milne S
Publication type: Article
Publication status: Published
Journal: International Journal of Psychiatry in Clinical Practice
Year: 2002
Volume: 6
Issue: 3
Pages: 163-165
ISSN (print): 1365-1501
ISSN (electronic): 1471-1788
Publisher: Informa Healthcare
URL: http://dx.doi.org/10.1080/136515002760276090
DOI: 10.1080/136515002760276090
Altmetrics provided by Altmetric
